No amendment in the last 12 months on an offering that may still be open — XCaliber Biotechnology, Inc. (latest filing Apr 14, 2020)
The latest filing for this offering is dated Apr 14, 2020 (first sale Apr 1, 2020). It reports $1,100,000 sold of $1,250,000 offered. No later amendment is in our index as of Oct 24, 2026.
What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.
Sources
- Form D · Apr 14, 2020 ↗ (Apr 14, 2020)
- XCaliber Biotechnology, Inc. — PartnerFacts page ↗ (Apr 14, 2020)